Journal of Enzyme Inhibition and Medicinal Chemistry

ISSN 1475-6366 · Taylor & Francis · United Kingdom · active 1874–2026

Metrics

Scimago quartile
Q2
Cites per paper (2y)
3.4
SJR
0.776
h-index
107

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Responding time

Submission to first decision
27 days (median)
Publisher-reported
Submission to post-review decision
42 days (median)
Publisher-reported
Acceptance to publication
21 days (median)
Publisher-reported
Submission to publication
~26 wk
DOAJ self-reported
Acceptance rate
38%
Publisher-reported

Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.

Indexing & access

DOAJScopusWeb of SciencePubMed

Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Article processing charge (APC): A$4,165 per accepted article (DOAJ). Fee waivers are available.

Official journal site →

Scope

synthesisbiologicalactivityorganicchemistryenzymefunctioninhibitionmolecularbiologycholinesteraseneurodegenerative

Frequently asked

Is Journal of Enzyme Inhibition and Medicinal Chemistry a predatory journal?

Our screening does not flag Journal of Enzyme Inhibition and Medicinal Chemistry. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.

Is Journal of Enzyme Inhibition and Medicinal Chemistry indexed in Scopus or Web of Science?

Per our venue index, Journal of Enzyme Inhibition and Medicinal Chemistry appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of Journal of Enzyme Inhibition and Medicinal Chemistry?

Papers in Journal of Enzyme Inhibition and Medicinal Chemistry are cited about 3.4 times each within two years of publication, and Scimago places it in Q2, with an h-index of 107. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is Journal of Enzyme Inhibition and Medicinal Chemistry (Q1, Q2, Q3, or Q4)?

Scimago places Journal of Enzyme Inhibition and Medicinal Chemistry in Q2 for its subject category. Quartiles split the journals in a field into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Journal of Enzyme Inhibition and Medicinal Chemistry is cited about 3.4 times per paper over two years, with an h-index of 107. A journal is ranked per subject category, so one spanning several fields can sit in different quartiles depending on the category.

What is the Web of Science (JCR) quartile of Journal of Enzyme Inhibition and Medicinal Chemistry?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Journal of Enzyme Inhibition and Medicinal Chemistry. The open equivalent is its Scimago quartile, Q2, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is Journal of Enzyme Inhibition and Medicinal Chemistry open access?

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

What is the article processing charge (APC) to publish in Journal of Enzyme Inhibition and Medicinal Chemistry?

Article processing charge (APC): A$4,165 per accepted article (DOAJ). Fee waivers are available. The exact charge can vary by article type and any fee waiver, so confirm the current amount on the journal's own site.

How long does Journal of Enzyme Inhibition and Medicinal Chemistry take to publish a paper?

Submission to first decision for Journal of Enzyme Inhibition and Medicinal Chemistry takes about 27 days (median) — Publisher-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Journal of Enzyme Inhibition and Medicinal Chemistry.

Ready to submit? Tools for your next paper

Compare the categoryHonest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Command palette

Jump anywhere, run any action.